Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Am J Kidney Dis. 2016 May 19;68(4):545–553. doi: 10.1053/j.ajkd.2016.03.429

Table 3.

Association Between Race/Ethnicity and Cardiovascular Events or All-Cause Death

Atherosclerotic Event or All-Cause Death Heart Failure or All-Cause Death
Model Non-Hispanic Black vs.
Non-Hispanic White
Hispanic vs.
Non-Hispanic White
Non-Hispanic Black vs.
Non-Hispanic White
Hispanic vs.
Non-Hispanic White
1 1.15 (0.98-1.35) 1.07 (0.74-1.55) 1.37 (1.17-1.60) 1.19 (0.84-1.68)
2 1.06 (0.89-1.25) 1.06 (0.72-1.56) 1.18 (1.00-1.39) 1.04 (0.73-1.49)
3 0.97 (0.82-1.15) 0.90 (0.61-1.34) 1.09 (0.92-1.28) 0.84 (0.59-1.22)
4 0.87 (0.73-1.04) 0.93 (0.62-1.38) 1.01 (0.85-1.20) 0.84 (0.58-1.22)
5 0.83 (0.69-0.99) 0.89 (0.60-1.33) 0.99 (0.83-1.18) 0.81 (0.56-1.18)
6 0.84 (0.70-1.00) 0.93 (0.62-1.38) 0.95 (0.80-1.14) 0.82 (0.56-1.19)
7 0.83 (0.69-1.00) 0.96 (0.65-1.43) 0.96 (0.80-1.14) 0.86 (0.59-1.25)

Note: Values are given as adjusted hazard ratio (95% confidence interval). Model 1: Clinical site; Model 2: Model 1 + sociodemographic characteristics, nephrology care; Model 3: Model 2+ baseline estimated glomerular filtration rate, proteinuria; Model 4: Model 3 + baseline cardiovascular risk factors, cardiovascular medication; Model 5: Model 4 + baseline markers mineral metabolism; Model 6: Model 4 + measures of anemia and inflammation (hemoglobin and C-reactive protein); Model 7: Model 4 + measures of subclinical ischemia (cardiac troponin I and T)